Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis

Ultrasound in Obstetrics and Gynecology

Volumn 51, Issue 1, 2018, Pages 64-76

  Gadalla, M A ^a,b   Huang, S ^b,c   Wang, R ^b   Norman, R J ^b   Abdullah, S A ^a   El Saman, A M ^a   Ismail, A M ^a   van Wely, M ^d   Mol, B W J ^b,e  

^a ASSIUT UNIVERSITY   (Egypt)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

anovulation; clomiphene; endometrial thickness; ovulation induction; PCOS

Indexed keywords

ANTIESTROGEN; CLOMIFENE; FERTILITY PROMOTING AGENT; TAMOXIFEN;

ANOVULATION; BIRTH RATE; COMPARATIVE STUDY; DRUG EFFECT; ENDOMETRIUM; FEMALE; HUMAN; LIVE BIRTH; META ANALYSIS; NEWBORN; OVULATION INDUCTION; PATHOLOGY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANOVULATION; BIRTH RATE; CLOMIPHENE; ENDOMETRIUM; ESTROGEN ANTAGONISTS; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFANT, NEWBORN; LIVE BIRTH; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAMOXIFEN;

EID: 85036596303     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.18933     Document Type: Review

References (72)

1. Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2013; 99: 63.
2. Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update 2015; 21: 411–426.
3. National Institute for Health and Clinical Excellence (NICE). Fertility: Assessment and Treatment for People with Fertility Problems. NICE: London, 2013.
4. Misso ML, Costello MF, Garrubba M, Wong J, Hart R, Rombauts L, Melder AM, Norman RJ, Teede HJ. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2013; 19: 2–11.
5. Kerin JF, Liu JH, Phillipou G, Yen SSC. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab 1985; 61: 265–268.
6. Brown J, Farquhar C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev 2016; 12: CD002249.
7. Misso ML, Wong JL, Teede HJ, Hart R, Rombauts L, Melder AM, Norman RJ, Costello MF. Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update 2012; 18: 301–312.
8. Moghetti P, Carmina E, De Leo V, Lanzone A, Orio F, Pasquali R, Toscano V. How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. J Endocrinol Invest 2015; 38: 1025–1037.
9. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014; 171: P1–P29.
10. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008; 23: 462–477.
11. Vause TD, Cheung AP, Sierra S, Claman P, Graham J, Guillemin JA, Lapensee L, Stewart S, Wong BC. Ovulation induction in polycystic ovary syndrome. J Obstet Gynaecol Can 2010; 32: 495–502.
12. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98: 4565–4592.
13. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016; 22: 687–708.
14. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome – Part 2. Endocr Pract 2015; 21: 1415–1426.
15. Boyle J, Teede HJ. Polycystic ovary syndrome – an update. Aust Fam Physician 2012; 41: 752–756.
16. Unfer V, Costabile L, Gerli S, Papaleo E, Marelli G, Di Renzo GC. Low dose of ethinyl estradiol can reverse the antiestrogenic effects of clomiphene citrate on endometrium. Gynecol Obstet Invest 2001; 51: 120–123.
17. Massai MR, de Ziegler D, Lesobre V, Bergeron C, Frydman R, Bouchard P. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril 1993; 59: 1179–1186.
18. Hsu C-C, Kuo H-C, Wang S-T, Huang K-E. Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility. Obstet Gynecol 1995; 86: 917–921.
19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1–e34.
20. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.handbook.cochrane.org [Accessed 1 January 2017].
21. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch ünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924–926.
22. Abu Hashim H, Bazeed M, Elaal IA. Minimal stimulation or clomiphene citrate as first-line therapy in women with polycystic ovary syndrome: a randomized controlled trial. Gynecol Endocrinol 2012; 28: 87–90.
23. Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J IntMed Res 2006; 34: 73–76.
24. Aygen EM, Güzel Z, Özgün T, Atakul T, Şahin Y. The use of letrozole for ovulation induction in infertile women with polycystic ovarian syndrome. Erciyes Tip Dergisi 2007; 29: 195–200.
25. Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 2009; 92: 849–852.
26. Badawy A, Gibreal A. Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS: a prospective randomized trial. Eur J Obstet Gynecol Reprod Biol 2011; 159: 151–154.
27. Bayar Ü, Basaran M, Kiran S, Coskun A, Gezer S. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertil Steril 2006; 86: 1447–1451.
28. Chen Z, Zhang M, Qiao Y, Yang J. Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pak J Med Sci 2016; 32: 1434–1438.
29. Dehbashi S, Dehbashi S, Kazerooni T, Robati M, Alborzi S, Parsanezhad ME, Shadman A. Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iran J Med Sci 2009; 34: 23–28.
30. El-Berry S, Razik MA. Nitric oxide donors increases pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertil Soc J 2010; 15: 106–109.
31. de Paula Guedes Neto E, Savaris RF, von Eye Corleta H, de Moraes GS, do Amaral Cristovam R, Lessey BA. Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome. Fertil Steril 2011; 96: 769–773.
32. Kamel HH. Role of phyto-oestrogens in ovulation induction in womenwith polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2013; 168: 60–63.
33. Kar S. Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial. J Hum Reprod Sci 2012; 5: 262–265.
34. Lima ML, Barbosa MA, Nastri CO, Ferriani RA, Navarro PA, Hossein-Rashidi B, Khandzad B, Shahrokh-Tehraninejad E, Bagheri M, Gorginzadeh M. Recombinant FSH compared to clomiphene citrate as the first-line in ovulation induction in polycystic ovary syndrome using newly designed pens: a randomized controlled trial. Ultrasound Obstet Gynecol 2016; 10: 42–48.
35. Maged AM, Elsawah H, Abdelhafez A, Bakry A, Al Mostafa W. The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with PolycysticOvary Syndrome. Gynecol Endocrinol 2015; 31: 635–638.
36. Mahran A, Abdelmeged A, Shawki H, Moheyelden A, Ahmed AM. Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: A RCT. Int J Reprod Biomed 2016; 14: 9–14.
37. Moini A, Ahmadi F, Jahangiri N, Ahmadi J, Akhoond MR. A randomized controlled trial evaluating the effect of ethinyl estradiol during clomiphene citrate cycles among women with polycystic ovary syndrome. Int J Gynaecol Obstet 2015; 131: 129–132.
38. Moussa AA, Torky H, Dief O, Elwahed AA, Senna HA. The effect of clomiphene citrate versus tamoxifen versus letrozol on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Med Int 2016; 3: 88–92.
39. Nahid L, Sirous K. Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol 2012; 64: 253–258.
40. Ray PB, Ray A, Chakraborti PS. Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Arch Gynecol Obstet 2012; 285: 873–877.
41. Roy K, Baruah J, Singla S, Sharma J, Singh N, Jain S, Goyal M. A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci 2012; 5: 20–25.
42. Sahin Y, Yirmibes U, Kelestimur F, Aygen E. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2004; 113: 214–220.
43. Salehpour S, Sene AA, Saharkhiz N, Sohrabi MR, Moghimian F. N-Acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. J Obstet Gynaecol Res 2012; 38: 1182–1186.
44. Selim MF, Borg TF. Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. J Gynecol Surg 2012; 28: 405–410.
45. Shahin AY, Mohammed SA. Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates – a randomized trial. Gynecol Endocrinol 2014; 30: 505–510.
46. Sheikh-El-Arab Elsedeek M, Elmaghraby HAH. Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertil Soc J 2011; 16: 125–130.
47. Elnashar A, Abdelmageed E, Fayed M, Sharaf M. Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod 2006; 21: 1805–1808.
48. Ismail AM, Hamed AH, Saso S, Thabet HH. Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2014; 180: 148–152.
49. Keikha F. Combination N-acetyl cysteine and clomiphene citrate in clomiphene citrate resistant polycystic ovary syndrome. Iran J Reprod Med 2010; 8: 12–13.
50. Refaeey A, Selem A, Badawy A. Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. Reprod Biomed Online 2014; 29: 119–124.
51. Hendawy SF, Samaha HE, Elkholy MF. Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clin Med Insights Reprod Health 2011; 5: 11–16.
52. Tredway D, Schertz JC, Bock D, Hemsey G, Diamond MP. Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: A phase II, randomized, dose-finding study. Fertil Steril 2011; 95: 1720–1724.e8.
53. Yang JS, Yoo EH, Lee JY, Hong SY, Shin JH, Park CH. A comparison of the effect of Anastrozole and Clomiphene citrate in anovulatory patients. Korean J Obstet Gynecol 2006; 49: 1723–1731.
54. Seyedoshohadaei F, Zandvakily F, Shahgeibi S. Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation. Iran J Reprod Med 2012; 10: 531–536.
55. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014; 371: 119–129.
56. Cantineau AEP, Cohlen BJ. Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Syst Rev 2007: CD005356.
57. George K, Kamath MS, Nair R, Tharyan P. Ovulation triggers in anovulatory women undergoing ovulation induction. Cochrane Database Syst Rev 2014: CD006900.
58. Moll E, van der Veen F, van Wely M. The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update 2007; 13: 527–537.
59. Roque M, Tostes AC, Valle M, Sampaio M, Geber S. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocrinol 2015; 31: 917–921.
60. Siebert TI, Viola MI, Steyn DW, Kruger TF. Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis. Gynecol Obstet Invest 2012; 73: 304–313.
61. Wang LL, Ren W, Cheng QF, Fan XD. Therapeutic effect of metformin for clomiphene-resistant infertility patients with polycystic ovary syndrome: a systematic analysis. Zhonghua Fu Chan Ke Za Zhi 2012; 47: 659–663.
62. Xiao J, Chen S, Zhang C, Chang S. The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis. Gynecol Endocrinol 2012; 28: 956–960.
63. Ding N, Chang J, Jian Q, Liang X, Liang Z, Wang F. Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol 2016; 32: 866–871.
64. He D, Jiang F. Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod Biomed Online 2011; 23: 91–96.
65. Wang R, Kim BV, van Wely M, Johnson NP, Costello MF, Zhang H, Ng EH, Legro RS, Bhattacharya S, Norman RJ, Mol BW. Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. BMJ 2017; 356: j138.
66. Franik S, Kremer JA, Nelen WL, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 2014: CD010287.
67. Legro RS, Zhang H. Letrozole or clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014; 371: 1463–1464.
68. Weiss NS, van Vliet MN, Limpens J, Hompes PGA, Lambalk CB, Mochtar MH, van der Veen F, Mol BWJ, van Wely M. Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis. Hum Reprod 2017; 32: 1009–1018.
69. Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson P, Christman GM, Ager J, Huang H, Hansen KR, Baker V, Usadi R, Seungdamrong A, Bates GW, Rosen RM, Haisenleder D, Krawetz SA, Barnhart K, Trussell JC, Ohl D, Jin Y, Santoro N, Eisenberg E, Zhang H. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med 2015; 373: 1230–1240.
70. Sharma S, Ghosh S, Singh S, Chakravarty A, Ganesh A, Rajani S, Chakravarty BN. Congenital malformations among babies born following letrozole or clomiphene for infertility treatment. PLoS One 2014; 9: e108219.
71. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006; 85: 1761–1765.
72. Forman R, Gill S, Moretti M, Tulandi T, Koren G, Casper R. Fetal safety of letrozole and clomiphene citrate for ovulation induction. J Obstet Gynaecol Can 2007; 29: 668–671.